Zimmer Holdings, Inc. a global leader in musculoskeletal care, has unveiled plans at the Chinese Orthopaedic Association (COA) International Congress to establish a new research and development centre in Beijing, China. According to the company the centre will lay the foundation for a network of research and development programs across the region.
“The Asia-Pacific region offers significant growth opportunities in both established and emerging markets,” said David C. Dvorak, President and CEO of Zimmer. “Investment in local research and development represents a critical component of Zimmer’s long-term strategy to provide clinically-relevant offerings for Asian markets.”
Zimmer’s Beijing-based research and development will be involved in collaborative efforts with local engineers and healthcare professionals with the goal of developing innovative products and technologies to meet the unique needs of Asian patients and their healthcare providers. Co-locating the centre with Zimmer’s existing operations in Beijing further strengthens the Company’s position in one of the fastest growing countries in the region. Furthermore it reinforces the belief that American corporates are looking outside US for growth as a result of the massive potential especially in the far East, coupled with a weak economic situation in their homeland and increased commercial pressure from President Obama’s Affordable Care Act, which is never far from the lips of corporate executives.